Evidence map›Paper›PMID 38612821›Full record

ArticleInternational journal of molecular sciences2024

Zinc(II) Iminopyridine Complexes as Antibacterial Agents: A Structure-to-Activity Study.

Silvia de la Mata Moratilla, Sandra Casado Angulo, Natalia Gómez-Casanova, José Luis Copa-Patiño, Irene Heredero-Bermejo, Francisco Javier de la Mata, Sandra García-Gallego

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Synthesis and structure of pyridinium tri-chlorido-(pyridine-κActa crystallographica. Section E, Crystallographic communications · 2026
    Article
  4. Complexes of Zinc(II) Chloride withPharmaceuticals (Basel, Switzerland) · 2026
    Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Silvia de la Mata MoratillaUniversity of Alcalá, Faculty of Sciences, Department of Organic and Inorganic Chemistry and Research Institute in Chemistry "Andrés M. del Río" (IQAR), 28805 Alcalá de Henares, Spain.ORCID 0009-0005-9605-5149
Sandra Casado AnguloUniversity of Alcalá, Faculty of Sciences, Department of Organic and Inorganic Chemistry and Research Institute in Chemistry "Andrés M. del Río" (IQAR), 28805 Alcalá de Henares, Spain.
Natalia Gómez-CasanovaUniversity of Alcalá, Faculty of Pharmacy, Department of Biomedicine and Biotechnology, 28805 Alcalá de Henares, Spain.ORCID 0000-0002-6983-1895
José Luis Copa-PatiñoUniversity of Alcalá, Faculty of Pharmacy, Department of Biomedicine and Biotechnology, 28805 Alcalá de Henares, Spain.ORCID 0000-0002-2162-3907
Irene Heredero-BermejoUniversity of Alcalá, Faculty of Pharmacy, Department of Biomedicine and Biotechnology, 28805 Alcalá de Henares, Spain.ORCID 0000-0001-6984-1965
Francisco Javier de la MataUniversity of Alcalá, Faculty of Sciences, Department of Organic and Inorganic Chemistry and Research Institute in Chemistry "Andrés M. del Río" (IQAR), 28805 Alcalá de Henares, Spain.ORCID 0000-0003-0418-3935
Sandra García-GallegoUniversity of Alcalá, Faculty of Sciences, Department of Organic and Inorganic Chemistry and Research Institute in Chemistry "Andrés M. del Río" (IQAR), 28805 Alcalá de Henares, Spain.ORCID 0000-0001-6112-0450
Universidad de Alcalá · ES

Funding

Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine CIBER-BBNComunidad de Madrid CM/BG/2021-01Ministerio de Ciencia e Innovación PID2020112924RB-100Ministerio de Ciencia e Innovación PID2020-113274RA-I00/AEI/10.13039/501100011033Ministerio de Universidades (Spain) BG20/00231University of Alcalá EPU-INV-UAH/2021/002University of Alcalá Introduction to Research 2023
6 · The paper itself

Abstract

Antibiotic resistance is currently a global health emergency. Metallodrugs, especially metal coordination complexes, comprise a broad variety of candidates to combat antibacterial infections. In this work, we designed a new family of Schiff base zinc(II) complexes with iminopyridine as an organic ligand and different inorganic ligands: chloride, nitrate, and acetate. The antibacterial effect of the Zn(II) complexes was studied against planktonic bacterial cells of

Indexed as

Coordination ComplexesZincAnti-Bacterial AgentsEscherichia coliLigandsNitratesPlanktonSchiff BasesAnti-Bacterial AgentsCoordination ComplexesLigandsNitratesSchiff BasesZincantibioticbacteriaEscherichia coliiminopyridinemetal complexSchiff baseStaphylococcus aureuszinc

Identifiers

PMID38612821
PMCPMC11012978
OpenAlexW4393944776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.